Disitamab Vedotin approved in china as first line therapy for HER2 expressing urothelial carcinoma

Ifinatamab Deruxtecan receives U.S. Priority Review for previously treated extensive-stage SCLC progressing after platinum-based chemotherapy

GlycoNex receives PMDA approval in Japan to initiate first-in-human phase 1 trial of GNX1021 in...

CSPC Pharmaceutical Group Limited obtains NMPA clinical trial approval for TF-targeted ADC SYS6051 in China

CrossBridge Bio enters an agreement to be acquired by Eli Lilly to advance next-generation dual-payload...

3B Pharmaceuticals and TetraKit Technologies announce strategic collaboration for joint radioligand therapy (RLT) development